Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Balsm Alofoq Medical Co's Enterprise Value is ﷼46.08 Mil.
Balsm Alofoq Medical Co does not have enough years/quarters to calculate its EBIT for the trailing twelve months (TTM) ended in Jun. 2026. Therefore, GuruFocus does not calculate Balsm Alofoq Medical Co's EV-to-EBIT at this moment.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Balsm Alofoq Medical Co's Enterprise Value is ﷼46.08 Mil.
Balsm Alofoq Medical Co does not have enough years/quarters to calculate its EBITDA for the trailing twelve months (TTM) ended in Jun. 2026. Therefore, GuruFocus does not calculate Balsm Alofoq Medical Co's EV-to-EBITDA at this moment.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Balsm Alofoq Medical Co's Enterprise Value is ﷼46.08 Mil.
Balsm Alofoq Medical Co does not have enough years/quarters to calculate its Revenue for the trailing twelve months (TTM) ended in Jun. 2026. Therefore, GuruFocus does not calculate Balsm Alofoq Medical Co's EV-to-Revenue at this moment.
EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow. As of today, Balsm Alofoq Medical Co's Enterprise Value is ﷼46.08 Mil.
Balsm Alofoq Medical Co does not have enough years/quarters to calculate its Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2026. Therefore, GuruFocus does not calculate Balsm Alofoq Medical Co's EV-to-FCF at this moment.
*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.
Balsm Alofoq Medical Co (SAU:9620) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
Balsm Alofoq Medical Co Enterprise Value Related Terms
Balsm Alofoq Medical Co Enterprise Value Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Balsm Alofoq Medical Co Enterprise Value Chart
Balsm Alofoq Medical Co Annual Data
Trend
Dec22
Dec23
Dec24
Dec25
Enterprise Value
-3.11
-1.75
76.06
58.82
Balsm Alofoq Medical Co Semi-Annual Data
Jun25
Dec25
Jun26
Enterprise Value
79.85
58.82
50.08
SAU:9620 vs ABT, SYK, MDT: Enterprise Value Comparison
For the Medical Devices subindustry, Balsm Alofoq Medical Co's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Balsm Alofoq Medical Co Enterprise Value vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Balsm Alofoq Medical Co's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Balsm Alofoq Medical Co's Enterprise Value falls into.
Balsm Alofoq Medical Co Enterprise Value Calculation
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Balsm Alofoq Medical Co's Enterprise Value for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Balsm Alofoq Medical Co (SAU:9620) has a Enterprise Value of ﷼46.08 Mil as of Sep. 22, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Balsm Alofoq Medical Co and its competitors.
Is Balsm Alofoq Medical Co's Enterprise Value too high?
Balsm Alofoq Medical Co's current Enterprise Value is ﷼46.08 Mil. Overall, Balsm Alofoq Medical Co has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does Balsm Alofoq Medical Co's Enterprise Value compare to ABT and SYK?
Balsm Alofoq Medical Co's Enterprise Value of ﷼46.08 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Medical Devices & Instruments company?
A good Enterprise Value depends on the Medical Devices & Instruments industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Balsm Alofoq Medical Co and its competitors. Balsm Alofoq Medical Co's current Enterprise Value is ﷼46.08 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Balsm Alofoq Medical Co stock overvalued right now?
Balsm Alofoq Medical Co (SAU:9620) has a current Enterprise Value of ﷼46.08 Mil. The current Enterprise Value is ﷼46.08 Mil. Balsm Alofoq Medical Co's overall GF Score™ is 21/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For Balsm Alofoq Medical Co (SAU:9620), the current Enterprise Value is ﷼46.08 Mil as of Sep. 22, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Balsm Alofoq Medical Co is a Saudi Arabian healthcare company operating in the medical services and medical supply sectors. Its activities include the operation of medical services, specialized clinics, and medical complexes, as well as the performance of medical operations. In addition, the company is engaged in the import and supply of medical devices and medical supplies, distributing these products across all regions of the Kingdom of Saudi Arabia. The company serves patients through its clinics and medical complexes while also supplying healthcare providers, hospitals, and other medical institutions with devices and consumables. Its revenue is generated through the provision of clinical and medical services and through the sale and distribution of imported medical equipment and supplies. The company operates primarily within the Saudi Arabian market, where its medical services and distribution activities are concentrated.
21GF Score
Get the complete analysis for SAU:9620
Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SAU:9620 has been successfully added to your 
